Entecavir Shortage Update: What Patients Need to Know in 2026

For patients managing chronic hepatitis B, few things are more alarming than hearing that your medication might be hard to find. Entecavir (Baraclude) is a cornerstone treatment—and for most patients, it's taken for life. So when questions about its availability arise, it's worth getting the facts straight.

Is There an Official Entecavir Shortage in 2026?

No. As of 2026, entecavir does not appear on the FDA's official drug shortage database. The FDA publicly tracks drug shortages and requires manufacturers to notify them of supply disruptions. The absence of entecavir from that list indicates no known nationwide manufacturing or supply crisis.

However, "no FDA shortage" does not mean every pharmacy near you has it on the shelf. Patients regularly report difficulty finding entecavir at their usual pharmacy, which stems from a combination of factors unrelated to any manufacturing crisis.

Why Patients Are Experiencing Localized Stockouts

Several structural factors make entecavir harder to find at any given pharmacy than more common medications:

• Small patient population: Chronic hepatitis B affects roughly 2.4 million people in the United States. That's a much smaller treatment population than conditions like hypertension or diabetes, so pharmacies order entecavir in smaller quantities.
• Specialty drug classification: Medicare Part D lists entecavir on Tier 4 (specialty tier), affecting how pharmacies handle it and which ones stock it regularly.
• Multiple generic manufacturers: Since Baraclude's patent expired, multiple companies now make generic entecavir. Pharmacies may switch between suppliers, and occasionally a specific manufacturer may have a brief production hiccup without triggering a formal FDA shortage.
• Oral solution is harder to find: The 0.05 mg/mL liquid form used by children and some adults is significantly less common at retail pharmacies than the 0.5 mg or 1 mg tablets.

A Brief History of Entecavir Availability

Entecavir was approved by the FDA in March 2005 under the brand name Baraclude. Bristol-Myers Squibb held the patent until approximately 2015 in the US. After patent expiration, multiple generic manufacturers entered the market, dramatically lowering prices. Generic entecavir retail prices dropped from several hundred dollars per month to as low as $11–$31 per 30-tablet supply with discount cards like GoodRx or SingleCare.

The drug is on the World Health Organization's List of Essential Medicines, reflecting its global importance in fighting hepatitis B—a virus that infects over 240 million people worldwide. In the US, availability has been relatively stable, though localized pharmacy stockouts persist.

Why You Cannot Simply Skip Doses While Waiting

The FDA's boxed warning for entecavir is explicit: severe acute exacerbations of hepatitis B have been reported in patients who discontinued treatment. After stopping entecavir, the hepatitis B virus can rebound aggressively, potentially causing liver failure. Your doctor must monitor your liver function closely for at least several months after any discontinuation.

This means: if you can't fill your prescription, contact your hepatologist or gastroenterologist immediately. Do not simply stop taking the medication while you search for a pharmacy.

What Hepatitis B Patients Should Do Right Now

If you're having trouble filling your entecavir prescription, here are the most important steps:

1. Use medfinder. medfinder calls pharmacies near you to find which ones have your medication in stock. You get a text with results.
2. Contact your prescriber. Tell them how many days' supply you have left. They may be able to provide samples or help you access a specialty pharmacy.
3. Ask for a 90-day supply. Going forward, ask your doctor to prescribe 90-day fills to reduce how often you face this issue.
4. Try a mail-order or specialty pharmacy. These pharmacies often have more stable supplies of specialty medications like entecavir.

Stay Ahead of Future Stockouts

The best defense is never letting your supply get low. Refill 7–10 days before running out, keep a list of pharmacies that stock entecavir, and use proactive tools. For a full toolkit, see our guide on how to find entecavir in stock near you.